Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.

Autor: Manickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, Mahalakshmy Thulasingam, Marie Gilbert Majella, Mathan Karuppiah, S A Rizwan, Arun Alexander, Sonali Sarkar, Sitanshu Sekhar Kar, Tamilarasu Kadhiravan, Aparna Bhatnagar, Prasanna Kumar S, Vivekanandan M Pillai, Pradeep Pankajakshan Nair, Rahul Dhodapkar, Pampa Ch Toi, Rakesh Singh, Nirupama Kasthuri, Girish C P Kumar, Saranya Jaisankar, Vaibhav Saini, Ankita Kankaria, Anuradha Raj, Amit Goyal, Vidhu Sharma, Satyendra Khichar, Kapil Soni, Mahendra Kumar Garg, Kalaiselvi Selvaraj, ShriKrishna B H, Kranti Bhavana, Bhartendu Bharti, C M Singh, Neha Chaudhary, Vijayaravindh R, Gopinath K, Karthikeyan Palaninathan, Simmi Dube, Rita Singh Saxena, Nikhil Gupta, A Rathinavel, S Priya, Arulsundareshkumar, Shama A Bellad, Avinash Kavi, Anilkumar S Harugop, Kailesh Pujary, Kirthinath Ballala, Sneha Deepak Mallya, Hanumanth M Prasad, D Ravi, N K Balaji, Raghuraj Hegde, Neha Mishra, Shalina Ray, S Karthikeyan, Sudha Ramalingam, A Murali, Sudhakar Vaidya, Mohit Samadhiya, Dhaval Bhojani, Somu Lakshmanan, Sudagar R B Singh, Nataraj Pillai, P Deepthi, K Banumathi, V Sumathi, D Ramesh, Sonam Poonam Nissar, Khushnood M Sheikh, Manisha N Patel, Vipul Shristava, Suresh S Kumar, K Shantaraman, Rajkamal D Pandian, Manoj Murhekar, Rakesh Aggarwal

Publikováno v: PLoS ONE, Vol 17, Iss 8, p e0272042 (2022)

BackgroundIn the ongoing COVID-19 pandemic, an increased incidence of ROCM was noted in India among those infected with COVID. We determined risk factors for rhino-orbito-cerebral mucormycosis (ROCM) post Coronavirus disease 2019 (COVID-19) among tho

Externí odkaz: https://doaj.org/article/999c6987be484763b79ae1a515fe4b43